Court nixes BMS block Of Mylan's Venezuela atazanavir exports
This article was originally published in Scrip
Executive Summary
Shortly after Gilead Sciences signed a historic deal with Indian generic companies for supplies of sofosbuvir to over 90 countries, another licensing agreement has reached a flashpoint. Bristol-Myers Squibb and Mylan are in court over rights to export atazanavir to Venezuela, with the first round in favor of Mylan.